Thomas Ruhstaller
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications
Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 16, 2026
Survival after pathological complete response following neoadjuvant chemotherapy versus chemoradiotherapy for oesophageal squamous cell carcinoma.
Journal: The British journal of surgery
Published: December 23, 2025
Conditional recurrence-free survival after curative esophagectomy: individual patient data analysis of 11 trials.
Journal: Journal of the National Cancer Institute
Published: October 08, 2025
Evaluation of pathological complete response as a surrogate endpoint for overall survival in resectable oesophageal cancer: integrated analysis of individual patient data from phase III trials.
Journal: The British journal of surgery
Published: March 30, 2025
Recurrence-free Survival as a Surrogate Endpoint for Overall Survival in Resectable Esophageal Cancer: Integrated Analysis of Individual Patient Data From Phase III Trials.
Journal: Annals of surgery
Published: March 30, 2025
Trends in use of neoadjuvant systemic therapy in patients with clinically node-positive breast cancer in Europe: prospective TAXIS study (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101).
Journal: Breast cancer research and treatment
Published: March 17, 2023
Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 15, 2022
Patterns of care for relapsed oesophageal cancer after initial curative trimodality therapy: Long-term follow-up of the SAKK 75/08 trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 24, 2022
Eribulin as first-line treatment in older patients with advanced breast cancer: A multicenter phase II trial [SAKK 25/14].
Journal: Journal of geriatric oncology
Published: February 02, 2022
Tailored axillary surgery in patients with clinically node-positive breast cancer: Pre-planned feasibility substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101).
Journal: Breast (Edinburgh, Scotland)
Published: July 30, 2021
Team functioning across different tumour types: Insights from a Swiss cancer center using qualitative and quantitative methods.
Journal: Cancer reports (Hoboken, N.J.)
Published: May 02, 2021
Last Updated: 09/26/2026